Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cognitive Impairment, Mild: early-phase trial registry
3 of 8 indexed Cognitive Impairment, Mild trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 3 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Cognitive Impairment, Mild: 8 US clinical trials tracked, 3 recruiting.
Cognitive Impairment, Mild is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Cognito Therapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition cognitive-impairment-mild
OPEN 3 | RECR 38% | LATE 1 | EARLY 3 | RANK #2176 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute-graft-versus-host Disease (38% recruiting · 8 trials)
Cognitive Impairment, Mild lists 3 open slots (38% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cognitive Impairment, Mild on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cognitive Impairment, Mild is recruiting below its size-band peers.
3 of 8 indexed trials (37.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cognitive Impairment, Mild trials is spread across many organizations.
Cognito Therapeutics accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Cognitive Impairment, Mild enrolment sits around 105 participants.
Median target enrolment is 105 among the 8 trials that report a genuine target (sentinel values excluded). 4 of those (50%) plan for fewer than 100 participants.
-
Cognitive Impairment, Mild research is mostly interventional.
6 interventional and 2 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Duke University
NCT04262206
Repurposing Siponimod for Alzheimer's Disease
St. Joseph's Hospital and Medical Center, Phoenix
NCT06639282
Pharmacological Modulation of Brain Oscillations in Memory Processing
University of Texas Southwestern Medical Center
NCT05594017
Acute Cognitive Changes During Atrial Fibrillation Episodes (AFCOG)
David Brunk, PA-C, MMS
NCT04033510
Multi-Center Study of Sensory Stimulation to Improve Brain Function
Cognito Therapeutics
NCT03556280
Anticipating Decline and Providing Therapy
Wake Forest University Health Sciences
NCT06182995
Speech, Linguistic and Acoustic Markers in Parkinson's Disease
University of Massachusetts, Worcester
NCT04273672
Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway
The University of Texas Health Science Center at San Antonio
NCT04200911
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Cognitive Impairment, Mild records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cognitive Impairment, Mild trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cognitive Impairment, Mild page
8 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Cognitive Impairment, Mild trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Cognito Therapeutics sponsors the most Cognitive Impairment, Mild trials on record, review their full trial history before evaluating a specific study. See Cognito Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cognitive Impairment, Mild condition card totals 8 registered trials; most-linked intervention Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.